News
Monday announced that it has earned a $100 million milestone payment from Sarepta Therapeutics (NASDAQ:SRPT). The milestone ...
The Kansas City Chiefs are in the middle of a tug of war between Missouri and Kansas. Arrowhead Stadium is loud and iconic, ...
Sarepta Therapeutics' licensing partner Arrowhead Pharmaceuticals said on Wednesday it expects to receive near-term milestone ...
The lefty became a three-time champion at the expense of three-time champion Alex Kolquist in Sunday's final at Ridgeview ...
Arrowhead Pharmaceuticals has moved to reassure Wall Street about its deal with Sarepta Therapeutics, telling investors that ...
Chiefs owner and CEO Clark Hunt said Monday the team has not made a final decision on its future stadium, but added there is ...
Ridgeview Country Club held the 99th Annual Arrowhead Invitational on Sunday. Alex Kolquist and Matt Mellin duked it out for ...
Chiefs president Mark Donovan said Tuesday he's "not sure which way" talks will go on the future of playing at Arrowhead, but ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $100 million milestone payment from Sarepta Therapeutics (NASDAQ: SRPT). The milestone was triggered when Arrowhead ...
Arrowhead Pharmaceuticals said it earned a $100 million milestone payment from Sarepta Therapeutics. The milestone was triggered when Arrowhead reached the first of two prespecified enrollment targets ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results